How Does DATA-Waiver Provider Patient Capacity Relate to Opioid and Buprenorphine Prescribing?
Link
Description
Explores if regulatory changes to increase the patient capacity among buprenorphine waivered providers effects buprenorphine and opioids prescription rates at the county-level. Compares prescription rates by metropolitan and non-metropolitan counties.
Author(s)
Robin Ghertner, Mir M. Ali
Date
12/2020
Type
Document
Organization
HHS Office of the Assistant Secretary for Planning and Evaluation
Tagged as
Access · Illicit drug use · Legislation and regulations · Pharmacy and prescription drugs · Prescription drug misuse · Rural-urban differences · Statistics and data
Related Content
Organizations (1)
- HHS Office of the Assistant Secretary for Planning and Evaluation, view details